Last Updated: September 24, 2026

Details for New Drug Application (NDA): 019647

✉ Email this page to a colleague

« Back to Dashboard

NDA 019647 describes POTASSIUM CITRATE, which is a drug marketed by Ut Sw Medctr, Ani Pharms, Ascent Pharms Inc, Bionpharma, Hibrow Hlthcare, Rising, Strides Pharma, Teva Pharms Usa Inc, Torrent, and Zydus Pharms, and is included in ten NDAs. It is available from twelve suppliers. Additional details are available on the POTASSIUM CITRATE profile page.

The generic ingredient in POTASSIUM CITRATE is potassium citrate. There is one drug master file entry for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the potassium citrate profile page.

Summary for 019647

Tradename:	POTASSIUM CITRATE
Applicant:	Ut Sw Medctr
Ingredient:	potassium citrate
Patents:	0

Medical Subject Heading (MeSH) Categories for 019647

Diuretics
Expectorants

Profile for product number 001

Active Rx/OTC/Discontinued:	DISCN	Dosage:	FOR SOLUTION;ORAL			Strength	20MEQ/PACKET Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons
Approval Date:	Oct 13, 1988	TE:		RLD:	Yes

Profile for product number 002

Active Rx/OTC/Discontinued:	DISCN	Dosage:	FOR SOLUTION;ORAL			Strength	10MEQ/PACKET Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons
Approval Date:	Oct 13, 1988	TE:		RLD:	Yes

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.